A paper has now been published in Diabetic Medicine journal. A link to the abstract can be found below. In addition a webinar has now been produced outlining some of the findings from the study which can be viewed below.
Lead investigator
Professor Julian Hamilton-Shield
Project coordinator
Dr Abdalmonem Majbar
Contact details
Level 6 UHBT Education Centre
Bristol Royal Hospital for Children
Upper Maudlin Street
Bristol BS2 8AE
»Ê¼Ò»ªÈË the study
Overview
There are two main types of diabetes: Type 1 and Type 2. In both types of diabetes, the patient’s blood sugar levels are high because there is not enough insulin, produced by the pancreas, to keep the blood sugar levels normal.
In Type 2 diabetes, the pancreas still makes insulin but not enough to meet individual’s needs as the person does not respond to insulin’s normal action. Too much glucose is made by the liver and cannot move into the cells of the body to be used for making energy. The pancreas has to work harder to make sufficient insulin to get glucose to go into these cells, but eventually gets worn out from this extra effort.
This study investigated Type 2 diabetes diagnosed in children and young people up to 17 years of age. Until recently this condition was not seen in children or adolescents, being a condition seen in adults. However there is growing evidence that the increase in childhood obesity has resulted in cases of Type 2 diabetes being diagnosed in younger age groups.
You can download the protocol card, including references, below.
Webinar and publications
Professor Julian Hamilton-Shield and Professor Timothy Barrett led a webinar on Type 2 Diabetes in Children and Young People in June 2021:
Published papers
- TP Candler, O Mahmoud, RM Lynn, AA Majbar, TG Barrett, JPH Shield. TP Candler, O Mahmoud, RM Lynn, AA Majbar, TG Barrett, JPH Shield. ''. Diabet Med. 2018 Jun;35(6):737-744. doi: 10.1111/dme.13609. Epub 2018 Mar 24.
Case definition
Please report any cases of children 0-17 years in the past month presenting with Type 2 diabetes as defined below. The American Diabetes Association criteria for diagnosis of diabetes will be used.
Exclusion criteria is as follows:
- type 1 diabetes (positive auto-antibodies and/or persisting insulin requirement from diagnosis)
- maturity Onset Diabetes of the Young (MODY) – suggested by a three generation, family history suggestive of dominantly inherited diabetes with normal weight
- diabetes developing in a person with known diabetes associated syndrome such as Prader-Willi, Alstrom or Bardet-Biedl syndromes
- a diagnosis of diabetes while on medical therapy with a known diabetogenic medication (e.g glucocorticoid, L-asparaginase, cyclosporine, tacrolimus, atypical antipsychotic, anticonvulsant)
- pancreatic failure (such as that after acute pancreatitis or pancreatectomy).
Analytic case definition
Any case of confirmed, newly diagnosed Type 2 diabetes using following criteria:
- confirmed by the presence of raised insulin level (>132 pmols/litre or equivalent) or raised C peptide level (>600 pmols/litre), or
- the patient is managed off insulin therapy for more than nine months in the absence of auto-antibodies typical of Type 1 diabetes.
The latter definition is likely to be based on a clinical re-evaluation after diagnosis of diabetes when a clinical course suggests a diagnosis other than type 1 diabetes.
Duration
April 2015 to April 2016 (13 months of surveillance). Follow-up until April 2017 (12 month follow-up).
Funding
NIHR grant through the Rare Disease Translational Research Consortium.
Approval
This study has been approved by NRES Committee South West (REC reference: 14/SW/1143) and has been granted Section 251 HRA-CAG permission (CAG reference: 15/CAG/0102).